RHUMBLINE ADVISERS - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 204 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.8%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$14,253,000
+23.1%
94,287
+18.6%
0.02%
+23.5%
Q2 2022$11,581,000
+56.4%
79,483
+27.2%
0.02%
+70.0%
Q1 2022$7,407,000
-15.8%
62,468
-2.1%
0.01%
-9.1%
Q4 2021$8,794,000
-1.3%
63,812
-0.5%
0.01%
-8.3%
Q3 2021$8,912,000
+48.7%
64,159
+3.9%
0.01%
+50.0%
Q2 2021$5,994,000
+69.0%
61,738
+19.0%
0.01%
+60.0%
Q1 2021$3,546,000
-29.6%
51,877
-11.7%
0.01%
-28.6%
Q4 2020$5,037,000
+36.9%
58,767
+3.9%
0.01%
+16.7%
Q3 2020$3,678,000
-28.1%
56,578
-19.1%
0.01%
-33.3%
Q2 2020$5,113,000
+169.5%
69,942
+25.5%
0.01%
+125.0%
Q1 2020$1,897,000
-32.0%
55,735
+8.7%
0.00%
-20.0%
Q4 2019$2,791,000
+39.3%
51,268
+6.7%
0.01%
+25.0%
Q3 2019$2,004,000
+6.4%
48,039
+11.7%
0.00%0.0%
Q2 2019$1,884,000
-7.6%
43,017
+8.5%
0.00%0.0%
Q1 2019$2,040,000
+50.1%
39,640
+7.9%
0.00%
+33.3%
Q4 2018$1,359,000
+49.8%
36,745
+52.1%
0.00%
+50.0%
Q3 2018$907,000
-10.0%
24,158
-5.3%
0.00%0.0%
Q2 2018$1,008,000
+40.0%
25,513
-8.7%
0.00%0.0%
Q1 2018$720,000
+203.8%
27,933
+218.4%
0.00%
Q4 2017$237,000
-40.0%
8,773
-16.9%
0.00%
-100.0%
Q3 2017$395,000
+53.7%
10,560
+2.8%
0.00%0.0%
Q2 2017$257,00010,2720.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders